Assura (ARSSF) Stock Price, News & Analysis

Company Overview

Assura PLC, trading as ARSSF on the OTC Markets, is a real estate investment trust specializing in primary healthcare facilities in the United Kingdom. The company acquires, develops and manages medical centres that are laid out for general practitioner (GP) practices, community health services and outpatient care. Assura structures long-term lease agreements with National Health Service (NHS) organisations and GP consortia, offering tailored financing and design solutions to meet evolving needs in primary care delivery.

Since its establishment in 2003, Assura has built a diversified portfolio of primary care assets across England and Scotland. The company’s projects range from new-build developments to portfolio acquisitions and refurbishments of existing practices. By focusing exclusively on primary healthcare real estate, Assura aims to deliver stable, inflation-linked rental income while supporting health service providers in securing modern, fit-for-purpose premises.

Headquartered in Altrincham, Cheshire, Assura is listed on the London Stock Exchange and abides by the regulatory framework governing UK real estate investment trusts. The company is managed by an experienced leadership team and overseen by an independent board of directors. Assura continues to pursue selective development and acquisition opportunities that align with its core strategy of partnering with NHS stakeholders and GP groups to enhance patient care infrastructure.

Key Stats

• Today's Range: $0.68 to $0.68
• 50-Day Range: $0.68 to $0.68
• 52-Week Range: $0.43 to $0.72
• Volume: N/A
• Average Volume: 9,153 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Real Estate
• Industry: REIT - Healthcare Facilities
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:ARSSF
• CIK: N/A
• Web: www.assuraplc.com
• Phone: 44-1925-420660
• Fax: N/A
• Employees: 86
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A